A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01445587

Recruitment Status : Withdrawn (Based on the clinical activity, not safety data, of the AKT inhibitor, GSK has decided at this time to suspend further development of GSK2110183 as monotherapy.)

First Posted : October 4, 2011

Last Update Posted : March 26, 2012

Sponsor:

Information provided by (Responsible Party):

GlaxoSmithKline

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Withdrawn
Actual Primary Completion Date :	November 2011
Estimated Study Completion Date :	November 2011

To Top